Report overview
This report contains market size and forecasts of Radioimmunotherapy in Global, including the following market information:
Global Radioimmunotherapy Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Radioimmunotherapy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Non Hodgkin Lymphoma (NHL) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Radioimmunotherapy include Bayer Healthcare Pharmaceuticals, BioSynthema, Clarity Pharmaceuticals, Curasight, Endocyte, Immunomedics, Molecular Insight Pharmaceuticals, Nordic Nanovector and PDL Biopharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Radioimmunotherapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Radioimmunotherapy Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Radioimmunotherapy Market Segment Percentages, by Type, 2021 (%)
Non Hodgkin Lymphoma (NHL)
Follicular Lymphoma
Solid Tumors
Breast Cancer
Ovarian Cancer
Osteosarcoma
Neuroblastoma
Prostate Cancer
Global Radioimmunotherapy Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Radioimmunotherapy Market Segment Percentages, by Application, 2021 (%)
Tumor Antigens
Radionuclides
Antibodies
Global Radioimmunotherapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Radioimmunotherapy Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Radioimmunotherapy revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Radioimmunotherapy revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer Healthcare Pharmaceuticals
BioSynthema
Clarity Pharmaceuticals
Curasight
Endocyte
Immunomedics
Molecular Insight Pharmaceuticals
Nordic Nanovector
PDL Biopharma
Philogen
RadioMedix
Stella Pharma
Telix Pharmaceuticals
